Back to Results
First PageMeta Content
Lung cancer / OSI Pharmaceuticals / Alkynes / Erlotinib / Targeted therapy / KRAS / Genentech / Bevacizumab / Epidermal growth factor receptor / Medicine / Chemistry / Pharmacology


Document Date: 2007-05-04 10:48:56

Open Document

File Size: 406,36 KB

Share Result on Facebook

City

Times Square / Lyon / Melville / /

Company

Chugai Pharmaceuticals Co. Ltd. / Synovate Inc. / Roche / Pfizer Inc. / Total U.S. net / Probiodrug / Genentech Inc. / Eyetech / AMD / Merck & Co Inc. / Eli Lilly and Company / Lilly / The NASDAQ Stock Market LLC Securities / Bristol-Myers Squibb Company / Novartis AG / DPIV / Prosidion Limited / OSI PHARMACEUTICALS INC. / Tandem Oncology Monitor / /

Continent

Europe / /

Country

France / Japan / United Kingdom / Wales / United States / /

Currency

USD / /

Event

Business Partnership / FDA Phase / M&A / Reorganization / General or Shareholder Meeting / /

IndustryTerm

protein product / tier biopharmaceutical organization / cancer therapy / mid-cap biotechnology / manufacturing / follow-on oncology product / therapies for patients suffering from cancer / therapy for metastatic pancreatic cancer / biotechnology / manufacturing costs / diabetes therapies / pharmaceutical / treatment of well over 100 / 000 cancer / biotechnology organization / combination product / /

MedicalCondition

ovarian cancer / complex tumor / oncology disease / American cancer / II diabetes / tumor / Inc. of cancer / cancer / tumors / NSCLC / macular disease / human cancer / diabetes / neovascular age-related macular degeneration / certain tumors / rash / obesity / advanced non-small cell lung cancer / solid cancers / pancreatic cancer / metastatic pancreatic cancer / lung cancer / advanced diabetes / diabetes /obesity / eye disease / /

MedicalTreatment

surgery / innovative therapies / chemotherapy / anti-cancer therapy / /

Organization

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington / D.C. / Medicare / FDA / American Cancer Society / European Union / Securities and Exchange Commission / Committee for Medicinal Products for Human Use / U.S. Food and Drug Administration / I.R.S. / NICE / International Agency for Research / /

Person

Roche / Genenetech / Colin Goddard / Robert A. Ingram / /

/

Position

Chief Executive Officer / Principal Executive / Chairman of the Board / /

Product

JanumetTM / Macugen / Avastin / Erbitux / Januvia / Tarceva / Lucentis / Novantrone / TORC1/ TORC2 / mitoxantrone / PSN9301 / VEGF agent / NSCLC / VEGFR-2 / TORC2 / OSI-906 / PSN010 / GLP-1 / OSI-930 / /

ProvinceOrState

Indiana / New York / Pennsylvania / Delaware / /

Technology

API / apoptosis / chemotherapy / treating cancer / biotechnology / cell signaling / /

URL

www.osip.com / /

SocialTag